{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:13:02Z","timestamp":1761718382889},"reference-count":41,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej14-0611","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T22:03:33Z","timestamp":1429221813000},"page":"485-492","source":"Crossref","is-referenced-by-count":6,"title":["The association between impaired proinsulin processing and type 2 diabetes mellitus in non-obese Japanese individuals"],"prefix":"10.1507","volume":"62","author":[{"given":"Hidenori","family":"Katsuta","sequence":"first","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachihiko","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Clinical Laboratory, Shimada Municipal Hospital, Shizuoka 427-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Sumitani","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Nishida","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Kondo","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Inukai","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, et al. (2003) Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. <i>Am J Physiol Endocrinol Metab<\/i> 285: E155-162.","DOI":"10.1152\/ajpendo.00104.2002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Roder ME, Porte D, Jr., Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. <i>J Clin Endocrinol Metab<\/i> 83: 604-608.","DOI":"10.1210\/jc.83.2.604"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Leahy JL, Bonner-Weir S, Weir GC (1992) Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. <i>Diabetes Care<\/i> 15: 442-455.","DOI":"10.2337\/diacare.15.3.442"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, et al. (1990) Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. <i>J Clin Endocrinol Metab<\/i> 70: 1247-1253.","DOI":"10.1210\/jcem-70-5-1247"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y (1988) Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. <i>Diabetologia<\/i> 31: 355-360.","DOI":"10.1007\/BF02341503"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Haffner SM, Gonzalez C, Mykkanen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. <i>Diabetologia<\/i> 40: 830-837.","DOI":"10.1007\/s001250050756"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pfutzner A, Kunt T, Langenfeld M, Lobig M, Knesovic M, et al. (2003) Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin. <i>Clin Chem Lab Med<\/i> 41: 1234-1238.","DOI":"10.1515\/CCLM.2003.189"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism. <i>Diabetes<\/i> 43: 511-517.","DOI":"10.2337\/diab.43.4.511"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Csorba TR (1991) Proinsulin: biosynthesis, conversion, assay methods and clinical studies. <i>Clin Biochem<\/i> 24: 447-454.","DOI":"10.1016\/S0009-9120(05)80001-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, et al. (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. <i>Biochem J<\/i> 260: 535-541.","DOI":"10.1042\/bj2600535"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Suzuki K, Kurose T, Takizawa M, Maruyama M, Ushikawa K, et al. (2005) Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor\/osteoprotegerin (OCIF\/OPG) on the decrease of bone mineral density. <i>Diabetes Res Clin Pract<\/i> 68: 117-125.","DOI":"10.1016\/j.diabres.2004.08.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ozawa S, Katsuta H, Suzuki K, Takahashi K, Tanaka T, et al. (2014) Estimated proinsulin processing activity of prohormone convertase (PC) 1\/3 rather than PC2 is decreased in pancreatic &beta;-cells of type 2 diabetic patients. <i>Endocr J<\/i> 61: 607-614.","DOI":"10.1507\/endocrj.EJ13-0506"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. American Diabetes Association (2003) Screening for type 2 diabetes. <i>Diabetes Care<\/i> 26: S21-24.","DOI":"10.2337\/diacare.26.2007.S21"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, et al. (2009) Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. <i>Diabetes Care<\/i> 32: 335-341.","DOI":"10.2337\/dc08-1478"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kahn SE, Halban PA (1997) Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. <i>Diabetes<\/i> 46: 1725-1732.","DOI":"10.2337\/diab.46.11.1725"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gadot M, Ariav Y, Cerasi E, Kaiser N, Gross DJ (1995) Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell. <i>Endocrinology<\/i> 136: 4218-4223.","DOI":"10.1210\/endo.136.10.7664638"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Laedtke T, Kjems L, Porksen N, Schmitz O, Veldhuis J, et al. (2000) Overnight inhibition of insulin secretion restores pulsatility and proinsulin\/insulin ratio in type 2 diabetes. <i>Am J Physiol Endocrinol Metab<\/i> 279: E520-528.","DOI":"10.1152\/ajpendo.2000.279.3.E520"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Stolerman ES, Manning AK, McAteer JB, Fox CS, Dupuis J, et al. (2009) TCF7L2 variants are associated with increased proinsulin\/insulin ratios but not obesity traits in the Framingham Heart Study. <i>Diabetologia <\/i>52: 614-620.","DOI":"10.1007\/s00125-009-1266-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kirchhoff K, Machicao F, Haupt A, Sch&auml;fer SA, Tschritter O, et al. (2008) Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. <i>Diabetologia<\/i> 51: 597-601.","DOI":"10.1007\/s00125-008-0926-y"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gonzalez-Sanchez JL, Martinez-Larrad MT, Zabena C, Perez-Barba M, Serrano-Rios M (2008) Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. <i>Diabetologia<\/i> 51: 1993-1997.","DOI":"10.1007\/s00125-008-1129-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. <i>Nat Genet<\/i> 38: 320-323.","DOI":"10.1038\/ng1732"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Furuta M, Carroll R, Martin S, Benediktsson R, Manolescu A, et al. (1998) Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31,32 proinsulin intermediates in islets of mice lacking active PC2<i>. J Biol Chem<\/i> 273: 3431-3437.","DOI":"10.1074\/jbc.273.6.3431"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Davidson HW, Rhodes CJ, Hutton JC (1998) Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. <i>Nature <\/i>333: 93-96.","DOI":"10.1038\/333093a0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP (1995) Elevated levels of authentic plasma hydroperoxides in NIDDM. <i>Diabetes<\/i> 44: 1054-1058.","DOI":"10.2337\/diab.44.9.1054"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Refaie S, Gagnon S, Gagnon H, Desjardins R, D&rsquo;Anjou F, et al. (2012) Disruption of proprotein convertase 1\/3 (PC1\/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion. <i>J Biol Chem<\/i> 287: 14703-14717.","DOI":"10.1074\/jbc.M111.323220"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Morgan D, Oliveira-Emilio HR, Keane D, Hirata AE, Santos da Rocha M, et al. (2007) Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. <i>Diabetologia<\/i> 50: 359-369.","DOI":"10.1007\/s00125-006-0462-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, et al. (2003) Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. <i>J Clin Invest<\/i> 112: 1831-1842.","DOI":"10.1172\/JCI200319774"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jeffrey KD, Alejandro EU, Luciani DS, Kalynyak TB, Hu X, et al. (2008) Carboxypeptidase E mediates palmitate-induced beta-cell ER stress and apoptosis. <i>Proc Natl Acad Sci USA<\/i> 105: 8452-8457.","DOI":"10.1073\/pnas.0711232105"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Berman Y, Mzhavia N, Polonskaia A, Devi LA (2001) Impaired prohormone convertases in Cpe(fat)\/Cpe(fat) mice. <i>J Biol Chem<\/i> 276: 1466-1473.","DOI":"10.1074\/jbc.M008499200"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Dickinson S, Colagiuri S, Faramus E, Petocz P, Brand-Miller JC (2002) Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. <i>J Nutr<\/i> 132: 2574-2579.","DOI":"10.1093\/jn\/132.9.2574"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sato Y, Komatsu M, Katakura M, Ohfusa H, Yamada S, et al. (2002) Diminution of early insulin response to glucose in subjects with normal but minimally elevated fasting plasma glucose. Evidence for early beta-cell dysfunction. <i>Diabet Med<\/i> 19: 566-571.","DOI":"10.1046\/j.1464-5491.2002.00746.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, et al. (2003) Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia. <i>Diabetes Care<\/i> 26: 1211-1215.","DOI":"10.2337\/diacare.26.4.1211"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hanley AJ, D&rsquo;Agostino R, Jr., Wagenknecht LE, Saad MF, Savage PJ, et al. (2002) Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. <i>Diabetes<\/i> 51: 1263-1270.","DOI":"10.2337\/diabetes.51.4.1263"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN (1999) Fasting proinsulin concentrations predict the development of type 2 diabetes. <i>Diabetes Care<\/i> 22: 262-270.","DOI":"10.2337\/diacare.22.2.262"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. <i>Diabetes Res Clin Pract<\/i> 87: 4-14.","DOI":"10.1016\/j.diabres.2009.10.007"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, et al. (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women&rsquo;s Health Initiative Observational Study. <i>Diabetes Care<\/i> 30: 1747-1752.","DOI":"10.2337\/dc07-0358"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Osei K, Rhinesmith S, Gaillard T, Schuster D (2004) Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. <i>Diabetes Care<\/i> 27: 1439-1446.","DOI":"10.2337\/diacare.27.6.1439"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Li CL, Tsai ST, Chou P (2003) Relative role of insulin resistance and beta-cell dysfunction in the progression to type 2 diabetes-The Kinmen Study<i>. Diabetes Res Clin Pract<\/i> 59: 225-232.","DOI":"10.1016\/S0168-8227(02)00249-8"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H (1996) A prospective analysis of the HOMA model. The Mexico City Diabetes Study. <i>Diabetes Care<\/i> 19: 1138-1141.","DOI":"10.2337\/diacare.19.10.1138"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, et al. (2002) Severe block in processing of proinsulin to insulin accompanied by elevation of des-64,65 proinsulin intermediates in islets of mice lacking prohormone convertase 1\/3. <i>Proc Natl Acad Sci USA<\/i> 99: 10299-10304.","DOI":"10.1073\/pnas.162352799"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nagi DK, Ali VM, Walji S, Jain SK, Yudkin JS (1996) Hyperinsulinemia in nondiabetic Asian subjects using specific assays for insulin, intact proinsulin, and des-31,32-proinsulin. <i>Diabetes Care<\/i> 19: 39-42.","DOI":"10.2337\/diacare.19.1.39"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T16:11:14Z","timestamp":1566576674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/6\/62_EJ14-0611\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0611","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}